当前位置: 首页 > 期刊 > 《疑难病杂志》 > 2007年第3期
编号:11417834
心血康治疗椎动脉型颈椎病的临床观察
http://www.100md.com 《疑难病杂志》 2007年第3期
颈椎病,椎动脉型;心血康注射液;临床疗效,,颈椎病,椎动脉型;心血康注射液;临床疗效,1资料与方法,2结果,3讨论,参考文献
     【摘 要】 目的 观察心血康治疗椎动脉型颈椎病的临床疗效。方法 60例椎动脉型颈椎病患者随机分为2组,对照组30例给予能量合剂+西比灵,治疗组30例加用心血康静脉滴注,疗程均为7 d,观察2组临床疗效。结果 2组治疗后显效率(80.0% vs 43.3%)和总有效率(96.7% vs 83.3%)差异有非常显著意义(P<0.01),治疗组明显高于对照组。2组治疗过程中,治疗组2例,对照组1例出现皮肤斑丘疹。随访3个月,治疗组无复发,对照组复发5例。结论 心血康治疗椎动脉型颈椎病起效快,疗效突出,副作用少,值得临床应用。

    【关键词】 颈椎病,椎动脉型;心血康注射液;临床疗效

    Therapeutic effect of Xinxuekang on vertebral-artery-type cervical spondylosis WANG Xiao-jun.Department of Internal Medicine,Hospital for Women and Children,Wuhan 430070,China

    【Abstract】 Objective To evaluate the therapeutic effect of Xinxuekang on vertebralarterytype cervical spondylosis (CSA).Methods 60 patients with CSA were randomly divided into treatment group (Xinxiekang plus routine therapy,n=30) and control group (routine therapy only,n=30).The clinical indexes changes after treatment were observed and clinical efficacy was evaluated.Results After treatment the effective rate and total effective rate in treatment group were 80%,96.67% respectively,however,which were 43.33%,83.33% respectively in control group.There were significant differences between two groups (P<0.01).Conclusion Xinxuekang is effective in treating CSA,with fast efficacy and few side effects,so which deserves to be used in clinic. ......

您现在查看是摘要页,全文长 6095 字符